Evidence map›Paper›PMID 35169289›Full record

ReviewNature reviews. Microbiology2022

Skeletal infections: microbial pathogenesis, immunity and clinical management.

Elysia A Masters, Benjamin F Ricciardi, Karen L de Mesy Bentley, T Fintan Moriarty, Edward M Schwarz, Gowrishankar Muthukrishnan

Open access · bronzeAbstract readReview
In one paragraph

Review in Nature reviews. Microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 334 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
334citing papers in PubMed, 1 pooled it
122.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

334 citing papers in PubMed, 1 synthesis or guideline pooled it, 614 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Antibiotic-Releasing Porous Shell Cements.Antibiotics (Basel, Switzerland) · 2026
    Article
  19. Article
  20. Article

274 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Elysia A MastersCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, USA.ORCID http://orcid.org/0000-0002-9981-624X
Benjamin F RicciardiCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, USA.ORCID http://orcid.org/0000-0001-9384-4840
Karen L de Mesy BentleyCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, USA.ORCID http://orcid.org/0000-0003-0176-1111
T Fintan MoriartyAO Research Institute Davos, Davos, Switzerland.ORCID http://orcid.org/0000-0003-2307-0397
Edward M SchwarzCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, USA. edward_schwarz@urmc.rochester.edu.ORCID http://orcid.org/0000-0002-4854-9698
Gowrishankar MuthukrishnanCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, USA.ORCID http://orcid.org/0000-0001-7521-6154
University of Rochester Medical Center · USAO Foundation · CH

Funding

Project 2: Defining the Protective vs. Susceptible Immune Proteome of S. aureus OsteomyelitisP50AR072000 · NIAMS · UNIVERSITY OF ROCHESTER · PI Edward M. Schwarz · 2017 to 2026
$13.6M
Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)P30AR069655 · NIAMS · UNIVERSITY OF ROCHESTER · PI Edward M. Schwarz · 2016 to 2026
$7.8M
NIAMS NIH HHS P30 AR069655NIAMS NIH HHS P50 AR072000
6 · The paper itself

Abstract

Osteomyelitis remains one of the greatest risks in orthopaedic surgery. Although many organisms are linked to skeletal infections, Staphylococcus aureus remains the most prevalent and devastating causative pathogen. Important discoveries have uncovered novel mechanisms of S. aureus pathogenesis and persistence within bone tissue, including implant-associated biofilms, abscesses and invasion of the osteocyte lacuno-canalicular network. However, little clinical progress has been made in the prevention and eradication of skeletal infection as treatment algorithms and outcomes have only incrementally changed over the past half century. In this Review, we discuss the mechanisms of persistence and immune evasion in S. aureus infection of the skeletal system as well as features of other osteomyelitis-causing pathogens in implant-associated and native bone infections. We also describe how the host fails to eradicate bacterial bone infections, and how this new information may lead to the development of novel interventions. Finally, we discuss the clinical management of skeletal infection, including osteomyelitis classification and strategies to treat skeletal infections with emerging technologies that could translate to the clinic in the future.

Indexed as

OsteomyelitisStaphylococcal InfectionsBiofilmsHumansImmune EvasionStaphylococcus aureus

Identifiers

PMID35169289
PMCPMC8852989
OpenAlexW4212885218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.